Causes
Idiopathic neuropathy: what it means when no cause is found
Idiopathic neuropathy means nerve damage, usually starting in both feet, for which no cause has been found after testing. It is common, especially after 50, and it usually changes slowly. The label is a working conclusion rather than a final verdict: a few tests are often missed, and a targeted second look sometimes finds a cause that can be treated.
Written by the Managing Neuropathy editorial team under the direction of Dr. Tom Biernacki, DPM, FACFAS · Clinical review pending · Last updated 11 October 2026

The short answer. “Idiopathic” means no cause was found. In most studies, roughly 1 in 4 to 1 in 3 people evaluated for polyneuropathy end up with this label, and it is more common in older adults. It usually begins after 50 with numbness, tingling or burning in the toes, creeps up slowly over years, and rarely becomes severely disabling, though it can still affect balance, walking, comfort and daily life. Before accepting the label, check that three tests were done: blood sugar, ideally including a glucose tolerance test if routine results were normal; vitamin B12 with methylmalonic acid; and serum protein immunofixation. No medicine is proven to slow the nerve damage itself, so treatment targets pain, balance, foot protection and the heart and metabolic risks that often travel with it.
What “idiopathic” means
Idiopathic simply means “of unknown cause.” Doctors use it when the history, the examination, blood tests and usually a nerve conduction study have not shown why the nerves are failing. It is a diagnosis of exclusion, and family doctors’ guidance calls it a presumptive one, which means it can be revisited if something new turns up. You may also see it called cryptogenic neuropathy.
When a nerve conduction study shows that the nerve fibers themselves are damaged, rather than their insulating coating, the full name is chronic idiopathic axonal polyneuropathy, or CIAP: a slowly creeping sensory, or sensory and motor, neuropathy of older adults. What “axonal” means on a nerve test report.
How common it is
Very. Peripheral neuropathy affects roughly 1 to 7 percent of the general population, more after 50, and in a large share of people no cause is ever found. Estimates of that share range from about a tenth to nearly half, depending on who is studied and how thoroughly. Family-medicine guidance puts it at 25 to 46 percent, rising with age; specialist clinics report lower figures; and in one Dutch population study, almost half of the middle-aged and older people found to have polyneuropathy had no cause.
It usually begins in a person’s 50s or later, and it is more common in men: in one large Dutch study, about two in three people with CIAP were men.
What it usually feels like
- Numbness, tingling or burning that starts in the toes and feet on both sides and creeps slowly upward. Once it reaches about the knees, the hands may begin to be affected.
- Pain in some people but not all: in a UK study of 50 people with CIAP, 22 had painful neuropathy. Burning pain is typical when mainly the small fibers are affected.
- Balance trouble, usually later in the course, such as unsteadiness in the dark or walking “more carefully.” Polyneuropathy is linked with walking problems and a higher risk of falls.
- Little or no weakness. Most people have full strength or only slight weakness of the ankles and toes. Marked weakness is a reason to look harder for another cause.
Numb feet, by pattern and cause.
Has everything been checked?
A neurology-led practice guideline from 2009, since reaffirmed, names the three blood tests most likely to turn up a problem in this kind of neuropathy. Family-medicine guidance adds a few routine ones. A complete work-up usually includes:
| Test | Why it matters |
|---|---|
| Blood glucose and, if routine results are normal or borderline, a 2-hour glucose tolerance test | Diabetes and prediabetes are the most common findings. The glucose tolerance test is the most sensitive check and can find prediabetes when the A1c is normal. |
| Vitamin B12 with methylmalonic acid | A “low-normal” B12 can hide a true deficiency. In one study of 27 people with neuropathy and B12 deficiency, 12 were found only by these extra tests. |
| Serum protein electrophoresis with immunofixation | Looks for an abnormal protein made by the immune system. One was found in 10 percent of people with otherwise unexplained neuropathy in a referral-center series. |
| Blood count, metabolic panel and thyroid test (TSH) | Routine first tests that pick up kidney, liver and thyroid problems. |
| Nerve conduction study and EMG | Confirms the pattern. Especially needed when symptoms came on quickly, are worse on one side, are mainly weakness, are getting worse fast, or persist when the first tests are normal. |
| Skin biopsy | Counts the small nerve fibers that carry pain and temperature, which a nerve conduction study cannot measure. |
| Genetic testing, in selected people | Considered when the neuropathy looks inherited: clumsiness since childhood, high arches, hammertoes, trouble fitting shoes, or a relative with neuropathy. |
Two of these are easy to miss. A 2012 University of Michigan study of US patients found that almost a quarter of people diagnosed with neuropathy had an expensive, low-yield MRI, while very few had the inexpensive glucose tolerance test. And methylmalonic acid is easy to skip when the B12 level is in the low-normal range. If your B12 was low-normal, or you take metformin, which can lower B12, ask whether methylmalonic acid was checked. How B12 deficiency neuropathy is tested and treated.
The history matters as much as the blood tests. Bring a list of every medicine and supplement, including doses. Too much vitamin B6, usually from supplements, can cause neuropathy; the US upper limit for adults is 100 mg a day, and Europe’s food safety agency has set a much lower limit of 12 mg a day. Some medicines can too, such as certain chemotherapy drugs and some antibiotics taken for months. Fluoroquinolone antibiotics, such as ciprofloxacin or levofloxacin, can cause nerve damage even after a short course. Ask your prescriber before stopping anything. Long-term heavy drinking is a known cause worth discussing openly. How much vitamin B6 is too much.
Causes that sometimes turn up later
- Prediabetes. Impaired glucose tolerance was found in 25 to 36 percent of people with idiopathic neuropathy, compared with 15 percent of people in comparison groups, and more often when the neuropathy was painful. Experts still debate how much it causes the nerve damage: in one UK controlled study, the difference could have been due to chance once age and sex were taken into account.
- Metabolic and heart-health risk factors. In a Dutch study, 55 percent of people with CIAP met the criteria for metabolic syndrome, compared with 34 percent of a comparison group from the general population. Waist size, blood pressure, blood fats and blood sugar have all been linked with neuropathy, even in people without diabetes.
- Sjögren’s disease, an autoimmune condition that often causes dry eyes and a dry mouth. When Sjögren’s affects the nerves, nerve symptoms can come before the Sjögren’s diagnosis in up to 90 percent of cases, and the dryness may be mild or go unnoticed, so it is worth asking about, especially for women.
- Celiac disease, which is sometimes checked, especially when the pattern is unusual. In one UK clinic series, biopsy-proven celiac disease was found in at least 9 percent of people with idiopathic neuropathy, compared with 1 percent of healthy controls.
- Inherited neuropathy, such as Charcot-Marie-Tooth disease, which can be mild enough to go unnoticed until later life. How Charcot-Marie-Tooth disease affects the feet.
How often does a second look find something? It depends on the kind of look. In a Dutch study that followed 75 people with CIAP for about five years, a definite cause turned up in only four, and simply repeating the same blood tests was not useful. Specialist neuromuscular centers sometimes find more. When a cause does turn up, it is often an inherited or inflammatory neuropathy, as in three of the four people in that Dutch study. So a targeted re-look is worthwhile, by a neuromuscular specialist, prompted by new or unusual symptoms or by a test that was never done. Re-running the same panel without a new reason is not.
Outlook
The outlook is usually reassuring. In the Dutch five-year study, the neuropathy progressed slowly and any handicap was not severe. In a later Dutch study, people with CIAP were still walking more than 10 years after it began, without severe disability. It is not harmless, though: it reduces quality of life. In the five-year study, nearly half of the people with the sensory and motor type needed a walking cane, and many also wore ankle braces, while only 1 of 21 people with the purely sensory type needed a cane.
Is it fatal? Idiopathic neuropathy is not described as a fatal condition. Large population studies have linked neuropathy, including in people without diabetes, with a higher risk of death, but that is an association, and one of them, in UK adults, suggested that part of it runs through metabolic factors such as blood sugar and waist size. That is one more reason to have blood pressure, blood fats, blood sugar and weight looked after. The real risks of neuropathy, explained.
Treatment
No drug has been proven to slow or reverse CIAP itself; a Cochrane review found no adequate trials. Treatment therefore targets what can be changed:
- Nerve pain. The UK’s NICE recommends starting with one of amitriptyline, duloxetine, gabapentin or pregabalin, and trying another if the first doesn’t help or isn’t tolerated. That advice covers nerve pain generally; the American Academy of Neurology’s guidance for diabetic nerve pain, the best-studied kind, lists the same families of medicines plus sodium-channel blockers and advises against opioids. The aim is to reduce pain, not necessarily to stop it: in trials, a reduction of about 30 percent counts as success. Several of these medicines can cause dizziness and sleepiness, which matters for balance. Neuropathy medicines compared.
- Balance and strength. Physical therapy with balance training is a core part of care, sometimes with a cane or brace. Strengthening exercise can build strength in weak muscles, and recent reviews in diabetic neuropathy found modest gains in balance, walking speed and leg strength, though they have not shown fewer falls, and trials specifically in idiopathic neuropathy are lacking. Exercises for neuropathy.
- Metabolic health. In a small 2006 study of 32 people with prediabetes-related neuropathy, with no comparison group, a year of diet and exercise counseling increased the number of small nerve fibers in skin biopsies by about a third, and pain improved, though people with the most nerve loss did not improve. In a University of Michigan study of people who had weight-loss surgery for obesity, nerve fiber density two years later had improved in the thigh and held steady in the lower leg. Stopping smoking also protects the feet.
- Foot protection. Check numb feet every day for blisters, cuts and calluses, wear well-fitting padded shoes and socks, and see a podiatrist regularly if your feet are at high risk. How to do a daily foot check.
Idiopathic small fiber neuropathy
When the damage is mainly in the small fibers that carry pain and temperature, burning feet can come with a normal nerve conduction study. A skin biopsy that counts nerve fibers is the test most often used to confirm it. About half or more of small fiber neuropathy stays idiopathic. Prediabetes has been found in up to half of the idiopathic cases, Sjögren’s disease accounts for nearly 10 percent of small fiber neuropathy, and B12 deficiency may be underdiagnosed, so those are worth checking.
It usually progresses slowly and then levels off, and a minority, up to about a third, later spread to the large fibers. In a Mayo Clinic study, most people with idiopathic small fiber neuropathy did not develop major disability, but they had more heart attacks than people without it, another reason to look after heart health. More on small fiber neuropathy.
When to ask for a neurologist or a second look
Family-medicine guidance suggests seeing a neurologist when the history, examination and first tests haven’t explained the neuropathy, and more urgently when symptoms came on quickly or are severe or getting worse. Ask for a fresh look if you notice any of these, because they don’t fit typical idiopathic neuropathy:
- one side much worse than the other, or patches rather than both feet evenly
- symptoms that came on over days or weeks, or are getting worse quickly
- weakness out of proportion to the numbness, or marked loss of balance and position sense
- symptoms that started in the hands, or a pattern that doesn’t begin at the toes
- weight loss, fever, joint inflammation, skin changes, or autonomic symptoms such as dizziness on standing, bowel or bladder changes, or changes in sweating
Which kind of doctor treats neuropathy.
When to get help urgently
- Go to an emergency department for weakness or tingling that is spreading over hours or days, and call 911 if you also have trouble breathing or swallowing. These can be signs of Guillain-Barré syndrome.
- Call 911 for sudden numbness or weakness of the face, arm or leg, especially on one side, or sudden trouble speaking, seeing or walking. These can be signs of a stroke.
- See a clinician the same day for a wound on a numb foot, or for redness, swelling or warmth in one. If the redness is spreading or you feel feverish, go to urgent care or an emergency department.
Common questions
Is idiopathic neuropathy serious?
Usually not in the sense of being dangerous. It typically progresses slowly over years and rarely becomes severely disabling. In a Dutch study, people with CIAP were still walking more than 10 years after it began, though some needed a cane or other walking aid. It can still lower quality of life through pain, numbness and unsteadiness, and numb feet need daily checks to prevent injuries.
Is idiopathic neuropathy fatal?
It is not described as a fatal condition. Population studies have linked neuropathy with a higher risk of death, including in people without diabetes, but that is an association that seems partly explained by metabolic factors such as blood sugar and waist size, which are worth treating in their own right. The more direct dangers are falls and unnoticed foot wounds, which is why balance work and daily foot checks matter.
Does idiopathic neuropathy get worse over time?
It can, but usually slowly. In a five-year Dutch follow-up of 75 people, progression was slow and any handicap was not severe. Faster worsening, new weakness or a change in the pattern is a reason to see a neurologist again.
Can idiopathic neuropathy be cured?
There is no proven treatment that reverses the nerve damage itself. Pain can often be reduced, balance training can help, and if a cause turns up later, such as low B12 or prediabetes, treating it may help. In one small study of prediabetes-related neuropathy, with no comparison group, diet and exercise increased small nerve fibers in the skin.
What tests should I ask about if my neuropathy is idiopathic?
Check that you have had blood glucose, ideally with a 2-hour glucose tolerance test if routine results were normal, vitamin B12 with methylmalonic acid, and serum protein immunofixation, plus a blood count, metabolic panel and thyroid test. Depending on your symptoms, a nerve conduction study, a skin biopsy, tests for Sjögren’s or celiac disease, or genetic testing may be added.
Related reading
Axonal neuropathy · Small fiber neuropathy · Vitamin B12 neuropathy · Nerve conduction study and EMG · Types of neuropathy · Can neuropathy be reversed? · Neuropathic pain
Sources and further reading: Castelli G et al., Peripheral neuropathy: evaluation and differential diagnosis, American Family Physician, 2020; Azhary H et al., Peripheral neuropathy: differential diagnosis and management, American Family Physician, 2010. England JD et al., Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing and the role of autonomic testing, nerve biopsy and skin biopsy (AAN, AANEM and AAPM&R, 2009). Warendorf J et al., Drug therapy for chronic idiopathic axonal polyneuropathy, Cochrane, 2017. Notermans NC et al., Chronic idiopathic axonal polyneuropathy: a five year follow up, Journal of Neurology, Neurosurgery and Psychiatry, 1994. Visser NA et al., Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome, Diabetes Care, 2013. Hughes RAC et al., A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy, Brain, 2004. Hanewinckel R et al., Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function, Journal of Neurology, Neurosurgery and Psychiatry, 2016. Samuelsson K, Press R, Microangiopathy: a potential contributing factor to idiopathic polyneuropathy, Frontiers in Neurology, 2018. Jacoby N, Anziska Y, A practical approach to diagnosing peripheral neuropathies, Seminars in Neurology, 2025. Mirian A et al., Diagnosis and management of patients with polyneuropathy, CMAJ, 2023. Laboratory testing for cryptogenic polyneuropathy, Practical Neurology (US), 2010. Tavee JO, Office approach to small fiber neuropathy, Cleveland Clinic Journal of Medicine, 2018. American Academy of Neurology, small fiber neuropathy study news release, 2021, and Oral and topical treatment of painful diabetic polyneuropathy, 2022. NICE, Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173). Sjögren’s Foundation, Clinical practice guideline for evaluation and management of peripheral nervous system manifestations in Sjögren’s disease, Arthritis Care & Research, 2025. Hadjivassiliou M et al., Neuropathy associated with gluten sensitivity, Journal of Neurology, Neurosurgery and Psychiatry, 2006. University of Michigan, news release on neuropathy testing, 2012. American Academy of Neurology, news release on diet and exercise in prediabetic neuropathy, 2006. Hicks CW et al., Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study, Annals of Internal Medicine, 2021, summarized by Johns Hopkins. Cochrane, Exercise for people with peripheral neuropathy, 2004. NIH Office of Dietary Supplements, Vitamin B6 and Vitamin B12 fact sheets. NINDS, peripheral neuropathy; NHS, peripheral neuropathy; Mayo Clinic, peripheral neuropathy. Vrancken AFJE et al., Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people, Archives of Neurology, 2002. van Dijk GW et al., Sjögren’s syndrome in patients with chronic idiopathic axonal polyneuropathy, Journal of Neurology, Neurosurgery and Psychiatry, 1997. Kim K et al., Associations of polyneuropathy with risk of all-cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status (UK Biobank), Journal of Diabetes Investigation, 2023. Pang X et al., Exploring the exercise for enhancing postural control, gait, and muscle strength in older adults with diabetic peripheral neuropathy: a systematic review and meta-analysis, Frontiers in Aging, 2025. Efficacy of exercise on balance, fear of falling, and risk of falls in patients with diabetic peripheral neuropathy: a systematic review and meta-analysis, Archives of Endocrinology and Metabolism, 2021. University of Michigan Institute for Healthcare Policy and Innovation, news release on weight-loss surgery and nerve fiber density, 2023. US Food and Drug Administration, safety communication on nerve damage from fluoroquinolone antibiotics, 2013. NINDS, Charcot-Marie-Tooth disease. Pop-Busui R et al., Diabetic neuropathy: a position statement by the American Diabetes Association, Diabetes Care, 2017. Warning signs: NINDS, Guillain-Barré syndrome; CDC, stroke signs and symptoms.
This page is general education and is not a diagnosis, a treatment plan, or a substitute for care from your own clinician. Clinical review by Dr. Biernacki is pending; the review date will be shown here once complete.
For our Michigan neighbors
Told your neuropathy
is idiopathic?
Protective sensation, balance risk and footwear can be checked directly, and the tests that are often missed can be reviewed. Dr. Biernacki’s Michigan practice can start that, alongside your neurologist or primary care clinician.
Everywhere else, take this page to your own clinician.
Dr. Tom Biernacki, DPM, FACFAS is a double board-certified foot and ankle surgeon (ABFAS and ABPM) and a Fellow of the American College of Foot & Ankle Surgeons. He is the founder of Balance Foot & Ankle in Howell and Bloomfield Township, Michigan, where peripheral neuropathy, diabetic foot risk and loss of protective sensation are part of his weekly clinic. His patient education videos have drawn more than 950,000 subscribers on YouTube. Managing Neuropathy is written by its editorial team under his direction, to put the explanation he gives in the exam room in front of the people who cannot get to one — including when a product is worth buying and when it is not.